plavix has been researched along with acetazolamide in 1 studies
| Studies (plavix) | Trials (plavix) | Recent Studies (post-2010) (plavix) | Studies (acetazolamide) | Trials (acetazolamide) | Recent Studies (post-2010) (acetazolamide) |
|---|---|---|---|---|---|
| 7 | 0 | 5 | 7,604 | 495 | 1,521 |
| Protein | Taxonomy | plavix (IC50) | acetazolamide (IC50) |
|---|---|---|---|
| Chain A, Class Iii Chitinase Chia1 | Aspergillus fumigatus A1163 | 164 | |
| Carbonic anhydrase 12 | Homo sapiens (human) | 0.3178 | |
| Renin | Homo sapiens (human) | 8.2 | |
| Carbonic anhydrase 1 | Homo sapiens (human) | 2.3173 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 1.2619 | |
| Carbonic anhydrase 2 | Bos taurus (cattle) | 0.7 | |
| Carbonic anhydrase 3 | Homo sapiens (human) | 1.95 | |
| Cathepsin B | Bos taurus (cattle) | 0.02 | |
| Steryl-sulfatase | Homo sapiens (human) | 0.025 | |
| Carbonic anhydrase 4 | Homo sapiens (human) | 0.1216 | |
| Carbonic anhydrase 6 | Homo sapiens (human) | 0.2925 | |
| Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | 0.1763 | |
| Carbonic anhydrase 7 | Homo sapiens (human) | 1.1737 | |
| Carbonic anhydrase 9 | Homo sapiens (human) | 0.464 | |
| Renin | Macaca mulatta (Rhesus monkey) | 8.2 | |
| Carbonic anhydrase 13 | Homo sapiens (human) | 0.23 | |
| Carbonic anhydrase 4 | Bos taurus (cattle) | 0.07 | |
| Carbonic anhydrase 13 | Mus musculus (house mouse) | 0.77 | |
| Carbonic anhydrase 14 | Homo sapiens (human) | 0.183 | |
| Carbonic anhydrase 5B, mitochondrial | Homo sapiens (human) | 0.23 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
1 other study(ies) available for plavix and acetazolamide
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |